VACCINE FOR PREVENTION OF LYME BORRELIOSIS

The invention provides a vaccine for prevention of Lyme borreliosis containing at least two types of chimeric poly epitope recombinant antigens, comprising immunodominant regions of OspA and OspC antigens, and at least one adjuvant and/or ferritin II. L'invention concerne un vaccin pour la prév...

Full description

Saved in:
Bibliographic Details
Main Authors BITTNER, LIBOR, LEDVINA, MIROSLAV, RASKA, MILAN, KRATOCHVILOVA, IRENA, VRZAL, VLADIMIR, WEIGL, EVZEN, KRUPKA, MICHAL, NEPERENY, JIRI, MASEK, JOSEF, TURANEK, JAROSLAV
Format Patent
LanguageEnglish
French
Published 12.11.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides a vaccine for prevention of Lyme borreliosis containing at least two types of chimeric poly epitope recombinant antigens, comprising immunodominant regions of OspA and OspC antigens, and at least one adjuvant and/or ferritin II. L'invention concerne un vaccin pour la prévention de la borréliose de Lyme contenant au moins deux types d'antigènes recombinants polyépitopes chimères, comprenant des régions immunodominantes d'antigènes OspA et OspC, et au moins un adjuvant et/ou de la ferritine II.
Bibliography:Application Number: WO2015CZ00042